Geographic accumulation of creutzfeldt-jakob disease in Slovakia - environmental metal imbalance as a possible cofactor

Central European Journal of Public Health

Volumn 19, Issue 3, 2011, Pages 158-164

  Slivarichová, Dana ^a   Mitrová, Eva ^a   Ursínyová, Monika ^a   Uhnáková, Iveta ^a   Koščová, Silvia ^a   Wsólová, Ladislava ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Cluster; Copper; Creutzfeldt jakob disease; Manganese; Metal imbalance

Indexed keywords

EID: 80053621885     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3667     Document Type: Article

References (38)

1. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992 Apr 16;356(6370):577-82.
2. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP. Further purification and characterization of scrapie prions. Biochemistry. 1982 Dec 21;21(26):6942-50.
3. Prusiner SB, McKinley MP, Bolton DC et al. Prions: methods for assay, purification and characterization. In: Maramorosch K, Koprowski H, editors. Methods in virology. New York: Academic press; 1984. p. 293-345.
4. Prusiner SB. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515-22.
5. Brown DR, Schmidt B, Groschup MH, Kretzschmar HA. Prion protein expression in muscle cells and toxicity of a prion protein fragment. Eur J Cell Biol. 1998 Jan;75(1):29-37.
6. Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis. 2000 Aug;7(4):270-3.
7. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature. 1997 Dec 18-25;390(6661):684-7.
8. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. Normal prion protein has an activity like that of superoxide dismutase. BiochemJ. 1999 Nov 15;344 Pt 1:1-5. Erratum in: Biochem J. 2000 Feb 1;345 Pt 3:767.
9. Brown DR, Hafiz F, Glasssmith LL, Wong BS, Jones IM, Clive C, et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J. 2000 Mar 15;19(6):1180-6.
10. Wong BS, Wang H, Brown DR, Jones IM. Selective oxidation of methionine residues in prion proteins. Biochem Biophys Res Commun. 1999 Jun 7;259(2):352-5.
11. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962-6.
12. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993 Mar 2;32(8):1991-2002.
13. Giese A, Levin J, Bertsch U, Kretzschmar H. Effect of metal ions on de novo aggregation of full-length prion protein. Biochem Biophys Res Commun. 2004 Aug 6;320(4):1240-6.
14. Tsenkova RN, Iordanova IK, Toyoda K, Brown DR. Prion protein fate governed by metal binding. Biochem Biophys Res Commun. 2004 Dec 17;325(3):1005-12.
15. Mitrová E, Belay G. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol. 2002;46(1):31-9.
16. Büchl A, Hawkesworth CJ, Ragnarsdottir KV, Brown DR. Re-partitioning of Cu and Zn isotopes by modified protein expression. Geochem Trans. 2008 Oct 10;9:11.
17. Brazier MW, Volitakis I, Kvasnicka M, White AR, Underwood JR, Green JE, et al. Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. J Neurochem. 2010 Jul;114(2):440-51.
18. Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J. 2002 Feb 15;362(Pt 1):253-8.
19. Barceloux DG. Manganese. J Toxicol Clin Toxicol. 1999;37(2):293-307.
20. Markesbery WR, Ehmann WD, Hossain TI, Alauddin M. Brain manganese concentrations in human aging and Alzheimer's disease. Neurotoxicology. 1984;5(1):49-57.
21. Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health. 1969 Nov;19(5):674-84.
22. Mitrová E. Some new aspects of CJD epidemiology in Slovakia. Eur J Epidemiol. 1991 Sep;7(5):439-49.
23. Wong BS, Chen SG, Colucci M, Xie Z, Pan T, Liu T, et al. Aberrant metal binding by prion protein in human prion disease. J Neurochem. 2001 Sep;78(6):1400-8.
24. Ursinyova M, Vanova R, Palusova O. Monitoring of dust deposition and its components in ambient air in Slovakia. AHEM. 1992;(2):1-21. (In Slovak.)
25. K. Air pollution in the Slovak Republic 2003. Bratislava: Ministry of Environment of the Slovak Republic, Slovak Hydrometeorological Institute; 2004. (In Slovak.)
26. M. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE? Med Hypotheses. 2000 Feb;54(2):278-306.
27. K. Analyses of metal levels in hair of children in Dolny Kubin and Oravska Lesna, 1983/1987/1995. Dolný Kubín: SZU Dolný Kubín; 1995 (In Slovak.)
28. Masánová V, Mitrova E, Ursinyova M, Uhnakova I, Slivarichova D. Manganese and copper imbalance in the food chain constituents in relation to Creutzfeldt-Jakob disease. Int J Environ Health Res. 2007 Dec;17(6):419-28.
29. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology. 1984;5(1):13-35.
30. Bastian F. CJD and other transmissible spongiform encephalopathies. St Louis: Mosby Year Book; 1991.
31. Banta RG, Markesbery WR. Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology. 1977 Mar;27(3):213-6.
32. Abdel-Naby S, Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatry. 1965 Jun;28:282-8.
33. Aschner M, Aschner JL. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev. 1991;15(3):333-40.
34. Mitrová E. Analytical epidemiology and risk factors of CJD. In: Court LA, Dormont D, Kingsbury DT, editors. Uncoventional virus diseases of the central nervous system. Paris: Masson; 1986. p. 19-28.
35. Oberdoester G, Cherian G. Manganese. In: Biological monitoring of toxic metals. New York: Plenum; 1988. p. 283-301.
36. Heilig E, Molina R, Donaghey T, Brain JD, Wessling-Resnick M. Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats. Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L887-93.
37. Legleiter LR, Liu HC, Lloyd KE, Hansen SL, Fry RS, Spears JW. Exposure to low dietary copper or low copper coupled with high dietary manganese for one year does not alter brain prion protein characteristics in the mature cow. J Anim Sci. 2007 Nov;85(11):2895-903.
38. Hesketh S, Sassoon J, Knight R, Brown DR. Elevated manganese levels in blood and CNS in human prion disease. Mol Cell Neurosci. 2008 Mar;37(3):590-8.